These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4355570)

  • 1. The effect of diazoxide in children with islet cell adenomas.
    Castro A; Dyess K; Buist N; Potts J
    Clin Biochem; 1973 Sep; 6(3):211-9. PubMed ID: 4355570
    [No Abstract]   [Full Text] [Related]  

  • 2. The insulin-glucose ration in children with islet cell tumors of the pancreas.
    Castro A; Buist NR
    Clin Biochem; 1974 Mar; 7(1):81-7. PubMed ID: 4363499
    [No Abstract]   [Full Text] [Related]  

  • 3. Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man.
    Fajans SS; Floyd JC; Thiffault CA; Knopf RF; Harrison TS; Conn JW
    Ann N Y Acad Sci; 1968 Apr; 150(2):261-80. PubMed ID: 4299219
    [No Abstract]   [Full Text] [Related]  

  • 4. Familial nesidioblastosis as the predominant manifestation of multiple endocrine adenomatosis.
    Vance JE; Stoll RW; Kitabchi AE; Buchanan KD; Hollander D; Williams RH
    Am J Med; 1972 Feb; 52(2):211-27. PubMed ID: 4400504
    [No Abstract]   [Full Text] [Related]  

  • 5. [Apropos of a case of severe hypoglycemia. Present possibilities of diagnosis and treatment].
    Fontaine R; Schneegans E; Haarscher A; Levy-Silagy J; Hasselmann JL; Meyer-Lutz ; Dorner M
    Ann Pediatr (Paris); 1968 Oct; 15(10):664-70. PubMed ID: 4304698
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic effects of diazoxide in normal subjects, patients with diabetes mellitus, and patients with organic hypoglycemia.
    Steinke J; Soeldner JS
    Ann N Y Acad Sci; 1968 Apr; 150(2):326-36. PubMed ID: 4299223
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha-cell function in a case of insulinoma.
    Santeusanio F; Brunetti P
    Horm Metab Res; 1976; Suppl 6():69-70. PubMed ID: 179933
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of insulin release by diazoxide and its relation to catecholamine effects in man.
    Porte D
    Ann N Y Acad Sci; 1968 Apr; 150(2):281-91. PubMed ID: 4299220
    [No Abstract]   [Full Text] [Related]  

  • 9. Diazoxide.
    Br Med J; 1972 Nov; 4(5837):417-8. PubMed ID: 4344353
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical use of diazoxide and studies of the mechanism of its hyperglycemic effects in man.
    Graber AL; Porte D; Williams RH
    Ann N Y Acad Sci; 1968 Apr; 150(2):303-8. PubMed ID: 4299222
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta cell adenoma in a child with hypoglycemia controlled with diazoxide.
    Balsam MJ; Baker L; Bishop HC; Hummeler K; Yakovac WC; Kaye R
    J Pediatr; 1972 May; 80(5):788-95. PubMed ID: 4336204
    [No Abstract]   [Full Text] [Related]  

  • 12. [Islet cell adenoma].
    Koch G
    Munch Med Wochenschr; 1971 Sep; 113(28):1217-20. PubMed ID: 4329246
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancreatic islet beta cell tumours.
    Johnston ID
    Proc R Soc Med; 1972 Oct; 65(10):849-50. PubMed ID: 4343556
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of insulin release to acute glycaemic stimulation with depression of basal insulin production rates in insulinoma following diazoxide administration.
    Bailey RE; Castro A; Kramer RM; Macfarlane D
    Acta Endocrinol (Copenh); 1970 Mar; 63(3):392-404. PubMed ID: 4317299
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Streptozotocin for islet-cell carcinoma.
    Lancet; 1973 Nov; 2(7837):1063-4. PubMed ID: 4127316
    [No Abstract]   [Full Text] [Related]  

  • 16. A morphological study on the mechanism of diazoxide-hyperglycemia (clinical and experimental investigation).
    Yoshinaga T
    Endokrinologie; 1969; 54(5):410-22. PubMed ID: 4188182
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of diphenylhydantoin upon glucose-induced insulin secretion in three patients with insulinoma.
    Hofeldt FD; Dippe SE; Levin SR; Karam JH; Blum MR; Forsham PH
    Diabetes; 1974 Mar; 23(3):192-8. PubMed ID: 4361409
    [No Abstract]   [Full Text] [Related]  

  • 18. Islet cell hyperinsulinism in adults and children.
    Liechty RD; Alsever RN; Burrington J
    JAMA; 1974 Dec; 230(11):1538-43. PubMed ID: 4372418
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of euglycaemic clamping in evaluation of diazoxide treatment of insulinoma.
    Skrha J; Svacina S; Srámková J; Páv J
    Eur J Clin Pharmacol; 1989; 36(2):199-201. PubMed ID: 2542036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical enhancement of tolbutamide-induced insulin release by diazoxide in a patient with islet cell hyperplasia.
    Schikman CH; Chertow BS; Fariss BL
    Acta Paediatr Scand; 1978 Sep; 67(5):671-6. PubMed ID: 358739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.